Type 2 diabetes mellitus with unspecified diabetic retinopathy
ICD-10 E11.31 is a billable code used to indicate a diagnosis of type 2 diabetes mellitus with unspecified diabetic retinopathy.
Type 2 diabetes mellitus is a chronic condition that affects the way the body metabolizes sugar (glucose), which is an important source of fuel for the body. In patients with type 2 diabetes, the body either resists the effects of insulin or doesn't produce enough insulin to maintain normal glucose levels. Diabetic retinopathy is a complication of diabetes that affects the eyes, specifically the retina, and can lead to vision impairment or blindness. The term 'unspecified' indicates that the specific type or stage of retinopathy has not been documented. This condition can develop in individuals with poorly controlled blood sugar levels over time, leading to damage to the blood vessels in the retina. Regular monitoring of HbA1c levels is crucial for managing diabetes and preventing complications, including retinopathy. Insulin management may be necessary for some patients, especially if oral medications are insufficient to control blood glucose levels. The presence of diabetic retinopathy signifies the need for comprehensive eye examinations and potential referrals to ophthalmology for further evaluation and treatment.
Thorough documentation of diabetes management, including HbA1c levels, medication adjustments, and complications.
Patients presenting with uncontrolled diabetes, requiring insulin therapy adjustments.
Ensure clear documentation of any referrals to ophthalmology for retinopathy evaluation.
Detailed notes on retinal examinations, findings related to diabetic retinopathy, and treatment plans.
Patients with diabetes presenting for routine eye exams or vision changes.
Document the specific type and severity of retinopathy when applicable.
Used when a patient with diabetes is evaluated for retinopathy.
Document findings of the eye examination and any treatment recommendations.
Ophthalmologists should ensure that the examination is thorough and includes a review of the patient's diabetes management.
The term 'unspecified' indicates that the specific type or stage of diabetic retinopathy has not been documented, which may affect treatment decisions and monitoring.
